Oddo BHF - Erytec Pharma : Refocus on solid tumours â€“ Buy confirmed

Report

Oddo BHF

Oussema Denguir

Erytec Pharma : Refocus on solid tumours â€“ Buy confirmed

>Feedback from conference call: strategic decision to refocus on solid tumours - On Monday, Erytech's management held a conference call following the announcement of a strategic refocus on solid tumours with blood cancer projects being shelved. This call clarified the reasons for this decision: there is a lack of commercial opportunity in acute lymphoblastic leukaemia (only some types of r/r ALL would have been targeted) given the tougher competition (Oncaspar, Erwina...

27/06/2018 5 EN

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Oussema Denguir

Other Reports from Oddo BHF

Maissa Keskes ... (+2)

Maissa Keskes
Stephane Houri

PVA Tepla : De multiples leviers de croissance qui soutiennent les objectifs 2028

>Opinion Surperformance et OC à 35 € maintenus - PVA Tepla a organisé hier son premier CMD dans son siège à Wettenberg. Ce CMD vient conforter le statut de croissance structurelle du groupe exposé à des multiples marchés en croissance. Il nous a également permis de mieux appréhender la stratégie et la vision jusqu’à 2028. Le groupe dispose, selon nous, d’une histoire de croissance solide sur plusieurs fronts, avec notamment le SiC comme moteur (20-25% des commandes du...

8m 8m 1 FR

Luis de Toledo Heras

Luis de Toledo Heras

Navigator : Volume growth sustains operating results at historical average levels

>Resilient margins as volume increase offsets lower average prices - Navigator’s results came in line with estimates (EBITDA margin of c.25%) with sales growth (+7% y-o-y, +9% q-o-q) supported by strong volumes (+29% in paper and packaging products y-o-y and +10% q-o-q and c.+20% at pulp on both an annual and quarterly basis) as demand restocking in the uncoated wood free segment continued in Q1 2024 (+1.5% y-o-y apparent demand growth and +10.4% in Europe due to the ...

14m 14m 1 EN

Florent Laroche-Joubert

Florent Laroche-Joubert

Merlin Properties : Very satisfactory operating performance overall in Q1

>Very satisfactory operating performance (FFO / share at € 0.15) - Yesterday evening Merlin Properties reported a very satisfactory operating performance in Q1 2024 with FFO/share at € 0.15 (-4.4% y-o-y in line with expectations due to the launch of data centres and higher financial costs) which includes overall growth at constant scope (l-f-l) of +3.8% in gross rental income, an occupancy rate of 95.8% (+100bp y-o-y; -40bp q-o-q) and positive reversion in its three ...

20m 20m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Erytec Pharma : Refocus on solid tumours â€“ Buy confirmed

PVA Tepla : De multiples leviers de croissance qui soutiennent les objectifs 2028

Navigator : Volume growth sustains operating results at historical average levels

Merlin Properties : Very satisfactory operating performance overall in Q1

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe